These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 38451261

  • 21. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
    Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):461-470. PubMed ID: 32081240
    [Abstract] [Full Text] [Related]

  • 22. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators*.
    Lancet; 2017 Nov 11; 390(10108):2160-2170. PubMed ID: 28859944
    [Abstract] [Full Text] [Related]

  • 23. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.
    Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677
    [Abstract] [Full Text] [Related]

  • 24. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 15; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 25. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 15; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 26. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 27. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F, Sole A, Singh G, Sorropago A, Sorropago G, Ballabeni C, Maccario M, Vettoretti S, Grassi G, Mancia G.
    J Hypertens; 2020 May 10; 38(5):936-942. PubMed ID: 31990900
    [Abstract] [Full Text] [Related]

  • 28. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
    Esler MD, Böhm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP.
    Eur Heart J; 2014 Jul 10; 35(26):1752-9. PubMed ID: 24898552
    [Abstract] [Full Text] [Related]

  • 29. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
    Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Dimitriadis K, Choi JW, East C, D'Souza R, Sharp ASP, Ewen S, Walton A, Hopper I, Brar S, McKenna P, Fahy M, Böhm M.
    Lancet; 2022 Apr 09; 399(10333):1401-1410. PubMed ID: 35390320
    [Abstract] [Full Text] [Related]

  • 30. Renal denervation for resistant hypertension.
    Coppolino G, Pisano A, Rivoli L, Bolignano D.
    Cochrane Database Syst Rev; 2017 Feb 21; 2(2):CD011499. PubMed ID: 28220472
    [Abstract] [Full Text] [Related]

  • 31. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F, Fezzi S, Gambaro A, Ederle F, Castaldi G, Widmann M, Gangemi C, Ferrero V, Pesarini G, Pighi M, Ribichini FL.
    J Nephrol; 2021 Oct 21; 34(5):1445-1455. PubMed ID: 33481223
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up of patients undergoing renal sympathetic denervation.
    Zeijen VJM, Feyz L, Nannan Panday R, Veen K, Versmissen J, Kardys I, Van Mieghem NM, Daemen J.
    Clin Res Cardiol; 2022 Nov 21; 111(11):1256-1268. PubMed ID: 35851428
    [Abstract] [Full Text] [Related]

  • 33. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
    Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T.
    J Hypertens; 2019 Sep 21; 37(9):1906-1912. PubMed ID: 31045964
    [Abstract] [Full Text] [Related]

  • 34. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2015 Dec 21; 104(12):1097-105. PubMed ID: 26306594
    [Abstract] [Full Text] [Related]

  • 35. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F.
    J Hypertens; 2015 Dec 21; 33(12):2512-8. PubMed ID: 26485461
    [Abstract] [Full Text] [Related]

  • 36. [Renal artery denervation for treating refractory hypertension].
    Benamer H, Louvard Y, Garot P, Unterseeh T, Hovasse T, Lefèvre T, Chevalier B, Morice MC.
    Ann Cardiol Angeiol (Paris); 2011 Dec 21; 60(6):354-60. PubMed ID: 22040858
    [Abstract] [Full Text] [Related]

  • 37. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis.
    Mufarrih SH, Qureshi NQ, Khan MS, Kazimuddin M, Secemsky E, Bloch MJ, Giri J, Cohen D, Swaminathan RV, Feldman DN, Alaswad K, Kirtane A, Kandzari D, Aronow HD.
    J Am Heart Assoc; 2024 Aug 20; 13(16):e034910. PubMed ID: 39140334
    [Abstract] [Full Text] [Related]

  • 38. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug 20; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

  • 39. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2015 Apr 07; 65(13):1314-1321. PubMed ID: 25835443
    [Abstract] [Full Text] [Related]

  • 40. Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis.
    Sesa-Ashton G, Nolde JM, Muente I, Carnagarin R, Macefield VG, Dawood T, Lambert EA, Lambert GW, Walton A, Esler MD, Schlaich MP.
    Hypertension; 2024 Jun 07; 81(6):e63-e70. PubMed ID: 38506059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.